A detailed history of Scw Capital Management, LP transactions in Axogen, Inc. stock. As of the latest transaction made, Scw Capital Management, LP holds 421,482 shares of AXGN stock, worth $6.31 Million. This represents 11.42% of its overall portfolio holdings.

Number of Shares
421,482
Previous 419,682 0.43%
Holding current value
$6.31 Million
Previous $3.44 Million 46.17%
% of portfolio
11.42%
Previous 7.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$8.14 - $12.25 $14,652 - $22,050
1,800 Added 0.43%
421,482 $5.02 Million
Q2 2022

Aug 10, 2022

BUY
$6.99 - $10.0 $1.02 Million - $1.46 Million
146,431 Added 53.59%
419,682 $3.44 Million
Q1 2022

May 13, 2022

BUY
$7.26 - $10.7 $1.98 Million - $2.92 Million
273,251 New
273,251 $2.17 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $633M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Scw Capital Management, LP Portfolio

Follow Scw Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scw Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Scw Capital Management, LP with notifications on news.